Skip to main content
Navigate Up
Sign In
 

New drug trial at CU Anschutz may be a cure to a strain of Leukemia


“When we combine these two regimens, just this pill and the low intensity chemo, we found that we can get most of our patients into a response of remission, that these remissions can last a very long time and that this is very well tolerated,” said Dan Pollyea, an oncologist at UCHealth [and associate professor of medicine at CU School of Medicine]. “91 percent of our patients ended up having the responses.”
 

9News, April 8, 2019

Read more